As stated above, pharmacological investigations involving Rac1 inhibitors have suggested Tiam1 (NSC23766), Vav2 (Ehop-016) and SoS1 as GEFs involved in sustained activation of Rac1 in the retina in diabetes (Figure 1). The gene discussed is VAV2; the disease is diabetes mellitus.